4//SEC Filing
Bellerophon Therapeutics, Inc. 4
Accession 0001104659-15-012181
CIK 0001600132operating
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 5:29 PM ET
Size
5.3 KB
Accession
0001104659-15-012181
Insider Transaction Report
Form 4
MEGLASSON MARTIN
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2015-02-13+1,995→ 1,995 totalExercise: $12.00Exp: 2025-02-12→ Common Stock (1,995 underlying)
Footnotes (1)
- [F1]This option was granted on February 13, 2015. This option vests as to 25% of the underlying shares on each one year anniversary of the date of grant.
Documents
Issuer
Bellerophon Therapeutics, Inc.
CIK 0001600132
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001600132
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 5:29 PM ET
- Size
- 5.3 KB